CNTF, STAT3 and new therapies for axonal degeneration: What are they and what can they do?

Expert Review of Neurotherapeutics

Volumn 13, Issue 3, 2013, Pages 239-241

  Selvaraj, Bhuvaneish Thangaraj ^a   Sendtner, Michael ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

amyotrophic lateral sclerosis; axon; CNTF; cytoskeleton; motoneuron diseases; neurodegeneration; neurotrophic factors; STAT3; stathmin; synapses

Indexed keywords

ALPHA SYNUCLEIN; ALPHA TUBULIN; AMYLOID; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOKINE RECEPTOR; FIBROBLAST GROWTH FACTOR; GDP 366; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; ONCOPROTEIN; ONCOPROTEIN 18; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN INHIBITOR; PROTEIN KINASE B; RECOMBINANT CILIARY NEUROTROPHIC FACTOR; STAT3 PROTEIN; STATHMIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CELL NUCLEUS; CELL SURVIVAL; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; ENZYME ACTIVITY; HUMAN; HUNTINGTON CHOREA; MOTOR NEURON DISEASE; NERVE FIBER; NERVE FIBER DEGENERATION; NEUROPATHOLOGY; NONHUMAN; OPTIC TRACT; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE;

ANIMALS; AXONS; CILIARY NEUROTROPHIC FACTOR; HUMANS; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; STAT3 TRANSCRIPTION FACTOR;

EID: 84874611341     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.13.9     Document Type: Review

References (16)

1. Selvaraj BT, Frank N, Bender FL, Asan E, Sendtner M. Local axonal function of STAT3 rescues axon degeneration in the pmn model of motoneuron disease. J. Cell Biol. 199(3), 437-451 (2012).
2. Wolfe MS. γ-secretase inhibitors and modulators for Alzheimer's disease. J. Neurochem. 120(Suppl. 1), 89-98 (2012).
3. Masliah E, Rockenstein E, Mante M et al. Passive immunization reduces behavioral and neuropathological deficits in an α-synuclein transgenic model of Lewy body disease. PLoS ONE 6(4), e19338 (2011).
4. Hua Y, Sahashi K, Rigo F et al. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 478(7367), 123-126 (2011).
5. Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 7(11), 616-630 (2011).
6. Pun S, Santos AF, Saxena S, Xu L, Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 9(3), 408-419 (2006).
7. Sendtner M, Schmalbruch H, Stöckli KA, Carroll P, Kreutzberg GW, Thoenen H. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358(6386), 502-504 (1992).
8. Sagot Y, Tan SA, Hammang JP, Aebischer P, Kato AC. GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. J. Neurosci. 16(7), 2335-2341 (1996).
9. Ben-Yaakov K, Dagan SY, Segal-Ruder Y et al. Axonal transcription factors signal retrogradely in lesioned peripheral nerve. EMBO J. 31(6), 1350-1363 (2012).
10. Tsokas P, Ma T, Iyengar R, Landau EM, Blitzer RD. Mitogen-activated protein kinase upregulates the dendritic translation machinery in long-term potentiation by controlling the mammalian target of rapamycin pathway. J. Neurosci. 27(22), 5885-5894 (2007).
11. Wegrzyn J, Potla R, Chwae YJ et al. Function of mitochondrial Stat3 in cellular respiration. Science 323(5915), 793-797 (2009).
12. Press C, Milbrandt J. Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress. J. Neurosci. 28(19), 4861-4871 (2008).
13. Nicolas CS, Peineau S, Amici M et al. The Jak/STAT pathway is involved in synaptic plasticity. Neuron 73(2), 374-390 (2012).
14. Thoenen H, Sendtner M. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat. Neurosci. 5(Suppl.), 1046-1050 (2002).
15. Verma NK, Dourlat J, Davies AM et al. STAT3-stathmin interactions control microtubule dynamics in migrating T-cells. J. Biol. Chem. 284(18), 12349-12362 (2009).
16. Shi X, Wang D, Ding K et al. GDP366, a novel small molecule dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells. Cancer Biol. Ther. 9(8), 640-650 (2010).